Telix Pharmaceuticals Limited announces highly positive top-line results from the pivotal Phase III ZIRCON study (Zirconium in Renal Cancer Oncology, NCT03849118) of its investigational...
Kintor Pharmaceutical Limited, a clinical-stage biotechnology company developing innovative small molecules and biological therapeutics, announced the enrollment and dosing of first patient in China...
The U.S. Air Force has awarded a Phase III Small Business Innovation Research (SBIR) contract to Electra.aero, Inc. ("Electra") to support the development of...
Pharma Two B Ltd., a privately held company developing innovative therapeutics based on reformulation and combinations of previously approved drugs for neurological indications, announced...
